Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy

E-ISSN： 1875-5828|13|1|68-83

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.13, Iss.1, 2016-01, pp. : 68-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Down’’s syndrome and Alzheimer’’s disease: two sides of the same coin

By Potter Huntington

Future Neurology, Vol. 3, Iss. 1, 2008-01 ,pp. : 29-37

Future Medicine

Access to resources Recommend Favorite

Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease

Current Alzheimer Research, Vol. 14, Iss. 12, 2017-10 ,pp. : 1305-1317

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberin – A New Molecular Target in Alzheimer’s Disease?

By Ferrando-Miguel Rosa Rosner Margit Freilinger Angelika Lubec Gert Hengstschläger Markus

Neurochemical Research, Vol. 30, Iss. 11, 2005-11 ,pp. : 1413-1419

Springer Publishing Company

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

Insulysin: An allosteric enzyme as a target for Alzheimer’s disease

By Song Eun Hersh Louis

Journal of Molecular Neuroscience, Vol. 25, Iss. 3, 2005-10 ,pp. : 201-206

Humana Press, Inc

Access to resources Recommend Favorite